Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned-Reference-Cited by-同舟云学术

Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned

Published:2018-11-02 Issue:11 Volume:17 Page:1005-1020
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Kilpeläinen Athina¹,Maya-Hoyos Milena²,Saubí Narcís¹^ORCID,Soto Carlos Y.²,Joseph Joan¹

Affiliation:

1. Catalan Center for HIV Vaccine Research and Development, AIDS Research Unit, Infectious Diseases Department, Hospital Clínic/IDIBAPS, School of Medicine, University of Barcelona, Barcelona, Spain

2. Chemistry Department, Faculty of Sciences, Universidad Nacional de Colombia, Ciudad Universitaria, Bogotá, Colombia

Funder

European Union’s Horizon 2020 research and innovation programme

Instituto de Salud Carlos III

ISCIII

Fundación Carolina, ‘Estancias Cortas Posdoctorales’ Program, Colciencias

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2018.1534588

Reference163 articles.

1. UNAIDS. Global AIDS Response Progress Reporting 2015, 2015.

2. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

3. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Experimental Determination of Protection Afforded by BCG Vaccination against Infection with Non-Tuberculous Mycobacteria: A Role in Cystic Fibrosis?;Vaccines;2023-08-01

2. Chimeric Human Papillomavirus-16 Virus-like Particles Presenting P18I10 and T20 Peptides from HIV-1 Envelope Induce HPV16 and HIV-1-Specific Humoral and T Cell-Mediated Immunity in BALB/c Mice;Vaccines;2022-12-21

3. Strategies to Develop a Mucosa-Targeting Vaccine against Emerging Infectious Diseases;Viruses;2022-03-03

4. Thirty years of recombinant BCG: new trends for a centenary vaccine;Expert Review of Vaccines;2021-07-13

5. BCG immunomodulation: From the ‘hygiene hypothesis’ to COVID-19;Immunobiology;2021-01